Literature DB >> 20212283

Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice.

Gongxiong Wu1, Ting Chen, Aliakbar Shahsafaei, Weiguo Hu, Roderick T Bronson, Guo-Ping Shi, Jose A Halperin, Huseyin Aktas, Xuebin Qin.   

Abstract

BACKGROUND: Complement system, an innate immunity, has been well documented to play a critical role in many inflammatory diseases. However, the role of complement in the pathogenesis of abdominal aortic aneurysm, which is considered an immune and inflammatory disease, remains obscure. METHODS AND
RESULTS: Here, we evaluated the pathogenic roles of complement membrane attack complex and CD59, a key regulator that inhibits the membrane attack complex, in the development of abdominal aortic aneurysm. We demonstrated that in the angiotensin II-induced abdominal aortic aneurysm model, deficiency of the membrane attack complex regulator CD59 in ApoE-null mice (mCd59ab(-/-)/ApoE(-/-)) accelerated the disease development, whereas transgenic overexpression of human CD59 (hCD59(ICAM-2+/-)/ApoE(-/-)) in this model attenuated the progression of abdominal aortic aneurysm. The severity of aneurysm among these 3 groups positively correlates with C9 deposition, and/or the activities of MMP2 and MMP9, and/or the levels of phosphorylated c-Jun, c-Fos, IKK-alpha/beta, and p65. Furthermore, we demonstrated that the membrane attack complex directly induced gene expression of matrix metalloproteinase-2 and -9 in vitro, which required activation of the activator protein-1 and nuclear factor-kappaB signaling pathways.
CONCLUSIONS: Together, these results defined the protective role of CD59 and shed light on the important pathogenic role of the membrane attack complex in abdominal aortic aneurysm.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212283      PMCID: PMC3057574          DOI: 10.1161/CIRCULATIONAHA.108.844589

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Detection and management of small aortic aneurysms.

Authors:  Robert W Thompson
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

2.  The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1.

Authors:  C Viedt; G M Hänsch; R P Brandes; W Kübler; J Kreuzer
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

3.  Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

Authors:  D S Holt; M Botto; A E Bygrave; S M Hanna; M J Walport; B P Morgan
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.

Authors:  M Mosorin; J Juvonen; F Biancari; J Satta; H M Surcel; M Leinonen; P Saikku; T Juvonen
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

5.  C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.

Authors:  J Hughes; M Nangaku; C E Alpers; S J Shankland; W G Couser; R J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2000-05

6.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility.

Authors:  Xuebin Qin; Nicole Krumrei; Luciano Grubissich; Martin Dobarro; Huseyin Aktas; Graciela Perez; Jose A Halperin
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

9.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Syndecans are differentially expressed during the course of aortic aneurysm formation.

Authors:  Jing Wen; Peiyi Wang; Sumona V Smith; Carolyn A Haller; Elliot L Chaikof
Journal:  J Vasc Surg       Date:  2007-10-01       Impact factor: 4.268

View more
  20 in total

1.  Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.

Authors:  Fengming Liu; Lin Wu; Gongxiong Wu; Chun Wang; Lining Zhang; Stephen Tomlinson; Xuebin Qin
Journal:  Atherosclerosis       Date:  2014-03-15       Impact factor: 5.162

2.  Role of complement cascade in abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Robert Erdman; Larry A Donoso; Tamara R Vrabec; Charles M Schworer; John H Lillvis; Amy M Boddy; Kimberly Derr; Alicia Golden; William D Bowen; Zoran Gatalica; Nikos Tapinos; James R Elmore; David P Franklin; John L Gray; Robert P Garvin; Glenn S Gerhard; David J Carey; Gerard Tromp; Helena Kuivaniemi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

3.  The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.

Authors:  Jinyan Zhang; Weiguo Hu; Wei Xing; Tao You; Junming Xu; Xuebin Qin; Zhihai Peng
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

Review 4.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

5.  The effect of human complement C3 protein applied at different times in treatment of polymicrobial sepsis.

Authors:  Yujie Yuan; Jianan Ren; Guosheng Gu; Shougen Cao; Jieshou Li
Journal:  Inflamm Res       Date:  2012-02-16       Impact factor: 4.575

6.  Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2019-04-13       Impact factor: 3.362

7.  The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model.

Authors:  Weiguo Hu; Richard Jin; Jinyan Zhang; Tao You; Zhihai Peng; Xiaowen Ge; Roderick T Bronson; Jose A Halperin; Joseph Loscalzo; Xuebin Qin
Journal:  Blood       Date:  2010-05-28       Impact factor: 22.113

8.  Heme oxygenase-1 in inflammation and cardiovascular disease.

Authors:  Meng-Ling Wu; Yen-Chun Ho; Chen-Yu Lin; Shaw-Fang Yet
Journal:  Am J Cardiovasc Dis       Date:  2011-07-28

Review 9.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 10.  Versatile cell ablation tools and their applications to study loss of cell functions.

Authors:  Fengming Liu; Shen Dai; Dechun Feng; Xiao Peng; Zhongnan Qin; Alison C Kearns; Wenfei Huang; Yong Chen; Süleyman Ergün; Hong Wang; Jay Rappaport; Elizabeth C Bryda; Anand Chandrasekhar; Bertal Aktas; Hongzhen Hu; Sulie L Chang; Bin Gao; Xuebin Qin
Journal:  Cell Mol Life Sci       Date:  2019-07-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.